Evidence map›Paper›PMID 29227472›Full record

ArticleNature chemical biology2018

Engineered synthetic scaffolds for organizing proteins within the bacterial cytoplasm.

Matthew J Lee, Judith Mantell, Lorna Hodgson, Dominic Alibhai, Jordan M Fletcher, Ian R Brown, Stefanie Frank, Wei-Feng Xue, Paul Verkade, Derek N Woolfson and 1 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 152 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Engineering COPlant communications · 2025
    Article
  9. Article
  10. Review
  11. Maturation and Conformational Switching of aJournal of the American Chemical Society · 2024
    Article
  12. Article
  13. Construction of an engineeredSynthetic and systems biotechnology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Engineering synthetic biomolecular condensates.Nature reviews bioengineering · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Matthew J LeeIndustrial Biotechnology Centre, School of Biosciences, University of Kent, Canterbury, UK.
Judith MantellSchool of Biochemistry, University of Bristol, Medical Sciences Building, University Walk, Bristol, UK.
Lorna HodgsonSchool of Biochemistry, University of Bristol, Medical Sciences Building, University Walk, Bristol, UK.
Dominic AlibhaiWolfson Bioimaging Facility, Medical Sciences Building, University Walk, Bristol, UK.
Jordan M FletcherSchool of Chemistry, University of Bristol, Cantock's Close, Bristol, UK.
Ian R BrownIndustrial Biotechnology Centre, School of Biosciences, University of Kent, Canterbury, UK.
Stefanie FrankDepartment of Biochemical Engineering, University College London, Bernard Katz Building, Gordon Street, London, UK.
Wei-Feng XueIndustrial Biotechnology Centre, School of Biosciences, University of Kent, Canterbury, UK.ORCID 0000-0002-6504-0404
Paul VerkadeSchool of Biochemistry, University of Bristol, Medical Sciences Building, University Walk, Bristol, UK.
Derek N WoolfsonSchool of Biochemistry, University of Bristol, Medical Sciences Building, University Walk, Bristol, UK.
Martin J WarrenIndustrial Biotechnology Centre, School of Biosciences, University of Kent, Canterbury, UK.ORCID 0000-0002-6028-6456
University of Bristol · GBUniversity of Kent · GBUniversity College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L01386X/1
6 · The paper itself

Abstract

We have developed a system for producing a supramolecular scaffold that permeates the entire Escherichia coli cytoplasm. This cytoscaffold is constructed from a three-component system comprising a bacterial microcompartment shell protein and two complementary de novo coiled-coil peptides. We show that other proteins can be targeted to this intracellular filamentous arrangement. Specifically, the enzymes pyruvate decarboxylase and alcohol dehydrogenase have been directed to the filaments, leading to enhanced ethanol production in these engineered bacterial cells compared to those that do not produce the scaffold. This is consistent with improved metabolic efficiency through enzyme colocation. Finally, the shell-protein scaffold can be directed to the inner membrane of the cell, demonstrating how synthetic cellular organization can be coupled with spatial optimization through in-cell protein design. The cytoscaffold has potential in the development of next-generation cell factories, wherein it could be used to organize enzyme pathways and metabolite transporters to enhance metabolic flux.

Indexed as

Alcohol DehydrogenaseBacillusBacterial ProteinsCytoplasmEscherichia coliLuminescent ProteinsMetabolic EngineeringMicroscopy, ConfocalProtein DomainsPyruvate DecarboxylaseAlcohol DehydrogenaseBacterial Proteinscitrine protein, bacteriaLuminescent ProteinsPyruvate Decarboxylase

Identifiers

PMID29227472
OpenAlexW2774231102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.